Recent content from Victor Stefanescu
Boston Scientific catheters treating AFib with extreme cooling linked to 4 deaths: FDA alert
Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don't need to do anything.
Boludo to pay $106K for labor violations across four Minneapolis restaurants
The U.S. Department of Labor found the Argentine pizza and empanada restaurant committed several violations across its four locations, including depriving workers of overtime pay and tips, illegally firing an employee and allowing a 15-year-old to work beyond permitted hours.
Boston Scientific pacemakers linked to two deaths subject of FDA safety alert
Boston Scientific said about 13% of devices from its Accolade family of pacemakers built before September 2018 have potential to malfunction.
Ending Minnesota's IPO drought, medtech company Anteris raises $88 million in NASDAQ listing
Anteris Technologies, which is creating a new kind of transcatheter heart valve for aortic stenosis, aims to compete with medtech giants like Medtronic.
![Abdi Farah, of south Minneapolis, tried on glasses at Warby Parker inside of Askov Finlayson Saturday afternoon. ] (AARON LAVINSKY/STAR TRIBUNE) aaron](https://arc.stimg.co/startribunemedia/UI7CRFGARC4B3EMBJFT7SP3PKU.jpg?h=120&w=180&fit=crop&bg=999&crop=faces)
Explore your options to keep costs in focus when buying new glasses
Take your prescription and shop around at the many optical retailers to find a pair of glasses that suits you and your budget.
McKesson to lay off more than 80 Minn. employees, close Rogers facility
The massive pharmaceuticals distributor said it is offering employees severance. It plans to begin layoffs on March 3.
Hearing issues are pervasive for veterans. A Minnesota-created test makes care easier.
AMTAS is growing in the VA system and oversees, while adoption in private health care settings in the U.S. is slow.
FAQ: Everything you need to know about Minnesota-based UnitedHealthcare
UnitedHealthcare, the nation's largest insurer, is owned by parent company UnitedHealth Group. UnitedHealthcare CEO Brian Thompson was fatally shot Wednesday.
Solventum, Minnesota's newest public company, laying off employees
The 3M health care spinoff has not disclosed how many of its 22,000 employees are affected.
Inside the procedure at the heart of a multibillion-dollar race to a safer AFib treatment
Medtronic, Boston Scientific and other medtech leaders are competing to commercialize catheter technology with roots in Minnesota that's making atrial fibrillation treatment safer.
Minnesota business leaders say Trump's proposed tariffs would result in higher prices for consumers
Canada, Mexico and China are Minnesota's biggest trading partners, and the tariffs could disrupt companies from 3M and Cargill to Target and Polaris.
In the doghouse: Bullseye mascot provider says Target owes $740K for breaching contract
A California company is claiming that the Minneapolis-based retailer did not cancel an auto-renewing contract for the use of its Bullseye English bullterrier dogs, in time.
Missed insulin doses cause complications. A new Medtronic app can detect when patients forget a dose.
The InPen app paves the way for the launch of the company's "Smart MDI" system combining a smart insulin pen that tracks doses and a monitor that makes real-time glucose readings for people who make multiple daily injections.
Medtronic races for market share in fast-growing treatment of irregular heartbeats
With supplier issue now resolved, the Minnesota-run medtech company expects to "reach and then exceed" market growth in the fast-growing sector for "pulsed field" atrial fibrillation treatments.
Recombinetics, which engineered hornless dairy bulls, files for bankruptcy
The Eagan-based company that edits animal genes faces $7.7 million in total liabilities.
Apple headphones can work as hearing aids. Minnesota-based Starkey says it welcomes competition.
Starkey CEO says the patient wins when there's more competition. "I like competition because that makes you better," CEO Brandon Sawalich says.
3M spinoff Solventum 'off to a solid start' but needs stronger growth
Solventum, Minnesota's newest major public company, raised its guidance Thursday and reported $2.08 billion in sales.
Second Trump presidency raises big questions for Minnesota health care
Observers say Trump administration may make changes to the Affordable Care Act, while Kennedy will seek government data on vaccine safety and other topics.
Chaska's Lifecore looks to growth in coming years after emerging from delisting challenge
The publicly traded biotech company's new CEO, Paul Josephs, said a new isolated filler can double revenue.
Minn. startup HistoSonics awarded $90 million for tumor-fighting tech at VA
The Plymouth-based company's novel ultrasound system destroys and liquefies liver tumors.
Native of St. Paul's Rondo neighborhood used NASA tech to revive shuttered company
Simpli-Fi Automation, the company Christopher Campbell founded, licensed federal innovations intended for space exploration and deployed them in the health care realm, developing products that use breath analysis to detect diseases.
3M spinoff Solventum considers selling filtration business: report
The company reported the business generated $238 million in the most recent financial quarter.
Boston Scientific lifts sales outlook, notes key approval of AFib device with Minnesota ties
The med-tech company with approximately 9,400 employees in Minnesota posted profit and sales that beat Wall Street's expectations.
Medtronic MiniMed insulin pumps recalled over shorter-than-expected battery life
Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin sooner than expected.
American Heart Association recognizes Twin Cities startups using AI to improve health equity
CorRen is focusing on peripheral artery disease detection, while Gumbo aims to break down language barriers in health care.
Abbott Labs sales boosted by double-digit medical devices growth
The CEO at the Illinois-based company with operations in Minnesota expects earning to return to a pre-pandemic profit model despite less demand for COVID-19 tests.
